Speaker illustration

Miss Ilona Cuijpers

KU Leuven, Leuven (Belgium)

DPP-4 inhibition by Linagliptin prevents cardiac inflammation, fibrosis, hypertrophy, and stiffness in obese ZSF1 rats.

Event: Frontiers in CardioVascular Biology 2018

Topic: Heart Failure

Session: Basic Science - Cardiac Diseases

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb